top
Search terms
Results 1 - 2 of 2 - ordered by :
Congress365

The Standard care versus Celecoxib Outcome Trial (SCOT); a randomized, trial comparing the cardiovascular safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs. The Standard ...

Date : 27/11/2017
Congress365

After 10 months follow-up, lixisenatide is safe in diabetic patients with recent ACS Long-term safety remains to be shown In randomized trial, celecoxib does not increase risk of CV events However, ...

Date : 05/09/2017